CA982481A - Pharmaceutical composition containing ethyl-2-(p-chlorophenoxy)-2-methyl-propionate and uracil-4-carboxylic acid - Google Patents
Pharmaceutical composition containing ethyl-2-(p-chlorophenoxy)-2-methyl-propionate and uracil-4-carboxylic acidInfo
- Publication number
- CA982481A CA982481A CA132,530A CA132530A CA982481A CA 982481 A CA982481 A CA 982481A CA 132530 A CA132530 A CA 132530A CA 982481 A CA982481 A CA 982481A
- Authority
- CA
- Canada
- Prior art keywords
- chlorophenoxy
- uracil
- propionate
- methyl
- carboxylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- KPLDRYODCDLNHB-UHFFFAOYSA-N 1-ethylpyrimidine-2,4-dione Chemical compound CCN1C=CC(=O)NC1=O KPLDRYODCDLNHB-UHFFFAOYSA-N 0.000 title 1
- KNHUKKLJHYUCFP-UHFFFAOYSA-N clofibrate Chemical compound CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 KNHUKKLJHYUCFP-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4196471A GB1368112A (en) | 1971-09-08 | 1971-09-08 | Chemical compositions for the treatment of hyperlipemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA982481A true CA982481A (en) | 1976-01-27 |
Family
ID=10422199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA132,530A Expired CA982481A (en) | 1971-09-08 | 1972-01-17 | Pharmaceutical composition containing ethyl-2-(p-chlorophenoxy)-2-methyl-propionate and uracil-4-carboxylic acid |
Country Status (4)
| Country | Link |
|---|---|
| CA (1) | CA982481A (2) |
| DE (1) | DE2244199A1 (2) |
| FR (1) | FR2152585B1 (2) |
| GB (1) | GB1368112A (2) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5800834A (en) * | 1996-06-10 | 1998-09-01 | Spireas; Spiridon | Liquisolid systems and methods of preparing same |
-
1971
- 1971-09-08 GB GB4196471A patent/GB1368112A/en not_active Expired
-
1972
- 1972-01-17 CA CA132,530A patent/CA982481A/en not_active Expired
- 1972-08-30 FR FR7230827A patent/FR2152585B1/fr not_active Expired
- 1972-09-08 DE DE19722244199 patent/DE2244199A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GB1368112A (en) | 1974-09-25 |
| FR2152585A1 (2) | 1973-04-27 |
| DE2244199A1 (de) | 1973-03-22 |
| FR2152585B1 (2) | 1976-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA990282A (en) | Polyamino acid derivatives and compositions containing same | |
| AU482733B2 (en) | Pharmaceutical compositions | |
| CA983854A (en) | Pharmaceutical composition containing nitroglycerin | |
| IL39988A0 (en) | Pyrazolopyrimidines and pharmaceutical compositions containing them | |
| IE35991L (en) | Camphor-containing pharmaceutical composition | |
| CA1011254A (en) | Pharmaceutical composition containing phosphonoacetic acid | |
| IL43722A0 (en) | Novel 2-aminomethyleneindanones and pharmaceutical compositions containing them | |
| CA974170A (en) | Pharmaceutical compositions | |
| PH10227A (en) | 1-substituted benzodiazepine-2-ones and pharmaceutical compositions containing the same | |
| GB1370904A (en) | Pharmaceutical composition | |
| IL37139A0 (en) | Triakoxybenzoyl aminoalkanoic acid derivatives and pharmaceutical compositions containing them | |
| CA982481A (en) | Pharmaceutical composition containing ethyl-2-(p-chlorophenoxy)-2-methyl-propionate and uracil-4-carboxylic acid | |
| GB1400842A (en) | Oxaprostanoic acid derivatives and pharmaceutical compositions containing the same | |
| AU461136B2 (en) | Pharmaceutical composition | |
| IL37141A0 (en) | Trialkoxybenzoyl aminoalkanoic acids and pharmaceutical compositions containing them | |
| CA982603A (en) | Process for preparing acid amides and pharmaceutical compositions containing same | |
| CA1012462A (en) | Pharmaceutical composition containing substituted anilides | |
| CA888686A (en) | Pharmaceutical compositions containing benzothiadiazines and pyrazinoylguanidines | |
| CA979808A (en) | Pharmaceutical composition containing 4-hydroxynicotinic acid | |
| IL39100A0 (en) | Novel pyrrolidine derivatives their preparation and pharmaceutical compositions containing them | |
| IL39516A0 (en) | Substituted 4-propoxy-9-fluoronone compounds and pharmaceutical compositions containing them | |
| PH14826A (en) | Arylpyrinidines and pharmaceutical compositions containing them | |
| CA880873A (en) | Pharmaceutical composition and method | |
| CA884857A (en) | Pharmaceutical composition | |
| CA885421A (en) | Pharmaceutical composition |